Orphanet: Networks
x

Search for a networks

* (*) mandatory field

Safety and dose finding study of different MOD-4023 dose levelscompared to daily r-hGH therapy in pre-pubertal growth hormonedeficient children

  • Type of network : Multinational clinical trials
  • Geographic coverage : European
  • Funding body(ies) : OPKO BIOLOGICS LTD. 
  • Sponsor : Information not provided
  • Website
  • Coordinator of multinational clinical trial

  • INFORMATION NOT PROVIDED
  • OPKO Biologics Ltd.
  • 16 Ashlagan st.
  • 8211804 KIRYAT GAT
  • ISRAEL
  • More information
  • Phone  : 00972-8-9300051
  • Fax  : -
  • Website
Last update: March 2018

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.